Presidio Medical has received an IDE approval from the FDA, enabling a pivotal study of its neuromodulation platform.

Epiminder has reported the outcomes from the landmark UMPIRE (sUb-scalp Monitoring ePileptic selzuREs) trial evaluating ...

Spanish company Aortyx has secured €13.8m ($15.8m) in a Series A financing round to further develop its bioresorbable patch, ...

GE HealthCare has released software combining its own imaging functionalities with tools enabled by a platform developed by ...

The health secretary addressed NHS employees a day after the £29bn NHS funding was announced. A £29bn investment into the ...

Amid ongoing trade policy debates, leaders from the medtech industry convened on Capitol Hill alongside the Advanced Medical ...

Wandercraft has raised $75m in a Series D funding round to introduce the self-balancing personal exoskeleton, Eve, to market ...

The US FDA has granted 510(k) clearance to Neurent Medical's NEUROMARK System for the treatment of individuals with chronic ...

Cognito has reported outcomes from a post hoc analysis of its OVERTURE trial, indicating that the Spectris AD can slow the ...

Sofinnova Partners has partnered with NVIDIA in a move intended to equip its life sciences portfolio companies with faster ...

Somnee announced that it has secured $10m in a seed extension round to advance its AI-powered neurotech sleep wearables.

Mainz Biomed has started the feasibility phase of the PancAlert project to develop a pancreatic cancer screening test.